|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0009566,
umls-concept:C0036186,
umls-concept:C0087086,
umls-concept:C0247025,
umls-concept:C0475224,
umls-concept:C0522523,
umls-concept:C0592046,
umls-concept:C0681842,
umls-concept:C1274040,
umls-concept:C1521840,
umls-concept:C1522318,
umls-concept:C1527362,
umls-concept:C1948041,
umls-concept:C2348205
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-4-3
|
|
pubmed:abstractText |
Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) carries a high risk of ischemic complications. However, there are scant recent data to identify which SVG lesions carry particularly high risk in recent years. We studied demographic and angiographic factors associated with ischemic complications after SVG PCI without distal protection in the TARGET (do tirofiban and reopro give similar efficacy trial?) study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1522-1946
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
623-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17192960-Aged,
pubmed-meshheading:17192960-Analysis of Variance,
pubmed-meshheading:17192960-Angioplasty, Balloon, Coronary,
pubmed-meshheading:17192960-Antibodies, Monoclonal,
pubmed-meshheading:17192960-Coronary Angiography,
pubmed-meshheading:17192960-Coronary Disease,
pubmed-meshheading:17192960-Double-Blind Method,
pubmed-meshheading:17192960-Female,
pubmed-meshheading:17192960-Graft Occlusion, Vascular,
pubmed-meshheading:17192960-Humans,
pubmed-meshheading:17192960-Immunoglobulin Fab Fragments,
pubmed-meshheading:17192960-Male,
pubmed-meshheading:17192960-Middle Aged,
pubmed-meshheading:17192960-Myocardial Infarction,
pubmed-meshheading:17192960-Platelet Aggregation Inhibitors,
pubmed-meshheading:17192960-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:17192960-Predictive Value of Tests,
pubmed-meshheading:17192960-Reoperation,
pubmed-meshheading:17192960-Research Design,
pubmed-meshheading:17192960-Risk Factors,
pubmed-meshheading:17192960-Saphenous Vein,
pubmed-meshheading:17192960-Survival Analysis,
pubmed-meshheading:17192960-Treatment Outcome,
pubmed-meshheading:17192960-Tyrosine,
pubmed-meshheading:17192960-Venous Thrombosis
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?).
|
|
pubmed:affiliation |
Department of Cardiology, Geisinger Medical Center, Danville, Pennsylvania 17822, USA. arunk@geisinger.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
